STOCK MARKET BSE NSE

Experts say new normal could lead to antimicrobial resistance

They say AMR may occur when telemedicine leads to over-prescribing of antibiotics

Published: 19th November 2020 06:21 AM  |   Last Updated: 19th November 2020 06:21 AM   |  A+A-

For representational purposes

Express News Service

THIRUVANANTHAPURAM: Virtual patient assessment through telemedicine has become the new normal in Covid-19 times. Meanwhile, health experts warn that without proper guidance or ground rules, the same may lead to another public health problem similar to that of a pandemic. Experts have cautioned against antimicrobial resistance (AMR) -- a condition in which bacteria/viruses and others no longer respond to medicines making infections harder to treat. According to them, AMR might occur when telemedicine leads to over-prescribing of unnecessary antibiotics as virtual assessment limits diagnostic capabilities. 

“The risk of over-prescribing can’t be overlooked. The same is the case with Covid-19 patients receiving antibiotics. It is high time that the officers overseeing the Kerala AMR Strategic Action Plan should consider this and come up with remedial measures,” said a microbiologist at a government hospital. 

Earlier, the World Health Organisation, in a document, said Covid-19 pandemic has presented potential threats that could affect antimicrobial stewardship activities and drive antimicrobial resistance. It also pointed out the scenario wherein individuals who have a mild disease without pneumonia or moderate disease with pneumonia receive antibiotics.

Besides, hospital admissions increase the risk of contracting other infections and the transmission of multi-drug-resistant organisms. This may lead to increased antimicrobial use, said a document released by the WHO. “Another potential threat is the wide use of biocidal agents for environmental and personal disinfection, including in non-health-care settings, which could also enhance the risk of cross-resistance to antibiotics,” it said.

The studies published in journals like the Lancet and Nature had also highlighted the need for taking the AMR seriously. A group of European clinicians in clinical microbiology and infection had stated antibiotic or antiviral treatment is appropriate for Covid patients who have co-infections. But those patients may be in a minority. Meanwhile, they also admit that it can be difficult to differentiate Covid-19 from bacterial pneumonia, which means that s ome patients without bacterial infections are receiving unnecessary antibiotics. 

“Considering the pandemic situation, telemedicine is being used for a limited time. The most effective way is personally examining a patient to understand the real condition. The telemedicine platform under e-Sanjeevani is being used now for initial diagnosis, follow-up and review cases, which so far turned to be of an effective one,” said Dr G S Vijayakrishnan, state secretary, Kerala Government Medical Officers’ Association.Meanwhile, he also said if the practice of virtual patient assessment continues for a long period, the threat of AMR can’t be ruled out. 

Who pointers

In certain cases, individuals who have mild disease without pneumonia receive antibiotics 

Another potential threat is the wide use of biocidal agents for personal disinfection which could also enhance the risk of cross-resistance to antibiotics



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp